TRANSACT TECHNOLOGIES INC (TACT): Results of Operations and Financial Condition

TransAct Technologies reported Q2 2026 progress shifting its Food Service Technology segment to higher-margin recurring SaaS. Software revenue grew 47% YoY, aided by price increases and ending free bundling, and BOHA! migration to Microsoft Azure. Full-year 2026 net sales guidance is $55M to $57M, adjusted EBITDA $1.5M to $2.0M. Tariff ruling cut net sales by $1M and EBITDA by $400k.

Tesla reported a 26% revenue increase to $22.5B in Q2, with net income of $1.11B, but negative free cash flow of $1.1B due to $5.79B in capital expenditures. The company's $43.5B cash position provides a buffer for growth investments in robotaxis, Optimus robots, and semiconductors. Tesla's market share in U.S. EVs has risen despite industry contraction, but competition from Chinese rivals like BYD persists.

Credo Technology Group (CRDO) reported $236.3M in adjusted profit and $82.9M in free cash flow for its fiscal first quarter. Shares fell 42.14% over the past month to $150.39, despite 18 of 19 analysts maintaining Buy ratings with a $281.47 consensus target. Revenue grew 114.7% year over year, but concerns arise over the gap between profit and cash flow.

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.

Amazon.com (AMZN) stock is down 13% from its 52-week high, despite AWS's 36.7% YOY revenue growth in Q2 2026. AWS's backlog of committed contracts reached $496 billion, with demand outpacing capacity. AWS's operating margin improved 520 basis points YOY, excluding energy contract gains. Management attributes growth to AI workloads and efficient capacity use.

ASML's High-NA technology is gaining traction among chipmakers like Samsung, Intel, and TSMC, crucial for its long-term outlook. Q2 earnings beat estimates with €7.59 EPS and €9.33B revenue. ASML raised full-year 2026 sales guidance to €43B-€45B. Analysts have a consensus 'Hold' rating, with a mean price target of $2,350.75, implying 56% upside.